CSTL

Castle BiosciencesF

Nasdaq / Health Care Equipment & Services

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

35%

Probability

Target price

$5.30

Analysis reference price unavailable

Analysis 2025-11-29 · RankAlpha Sentiment AI

Most likely

Base case

40%

Probability

Target price

$3.60

Analysis reference price unavailable

Analysis 2025-11-29 · RankAlpha Sentiment AI

B-

Bear case

25%

Probability

Target price

$2.40

Analysis reference price unavailable

Analysis 2025-11-29 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-11-29

AI commentary

Market tone is cautious-to-mixed with emphasis on reimbursement newsflow and quarterly results as primary drivers; recent trading shows low absolute prices and elevated volatility suggesting risk-averse positioning [#PR-2024-11-01], [#10-Qp34]. Analysts and investors focus on near-term cash runway and adoption metrics.

RankAlpha Sentiment AI - 2025-11-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

-eventUpcoming clinical / product updatesHigh impact

Potential assay validation or commercialization updates that could materially affect revenue guidance and reimbursement adoption [#10-Qp12].

2026-02-20catalystQuarterly earnings miss / guidance cutHigh impact

Weak revenue or slower test adoption could trigger downward revisions and near-term selling pressure [#10-Qp34].

2026-06-30catalystReimbursement / payer expansionHigh impact

Broader payer coverage for diagnostic tests could increase addressable market and margins [#PR-2024-11-01].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-11-29 • Updated nightlySource: Internal modelMethodology